Literature DB >> 2476666

Stable association of activated pp60src with two tyrosine-phosphorylated cellular proteins.

A B Reynolds1, S B Kanner, H C Wang, J T Parsons.   

Abstract

We have identified two phosphotyrosine-containing cellular proteins with relative molecular masses of 130,000 (pp130) and 110,000 (pp110) daltons in chicken embryo cells that coimmunoprecipitated with pp60v-src and activated forms of chicken pp60c-src (pp60(527)F). Most if not all of the tyrosine-phosphorylated forms of pp130 and pp110 could be immunoprecipitated from lysates with any of several src protein-specific monoclonal antibodies directed against at least three spatially distinct epitopes. Consequently, of the more than 15 prominent phosphoproteins detected on immunoblots with phosphotyrosine-specific antibodies, pp130 and pp110 were selectively removed by src protein-specific immunoprecipitation, and their presence in the immunoprecipitates appears to have been due to a direct interaction with activated src proteins. src protein variants that induce different morphological phenotypes were altered in their ability to form detergent-stable complexes with pp130 and pp110 or with pp110 alone. Mutant src proteins, defective for myristylation, showed increased tyrosine phosphorylation of and association with pp110. Expression of src variants with mutations in the A box (pp60dl92/527F) or B box (pp60dl155/527F) of the src homology region induced differences in phosphorylation of pp130 and pp110, as well as changes in their association with variant src proteins. Sequences within the B-box region appeared to be necessary for stable complex formation with pp130 and pp110 and may be involved in the interaction of activated src proteins with cellular substrates.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2476666      PMCID: PMC362457          DOI: 10.1128/mcb.9.9.3951-3958.1989

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  63 in total

1.  Genetic analysis of the form and function of the viral src oncogene product.

Authors:  J A Wyke; A W Stoker
Journal:  Biochim Biophys Acta       Date:  1987-04-20

2.  Cell transformation by pp60c-src mutated in the carboxy-terminal regulatory domain.

Authors:  C A Cartwright; W Eckhart; S Simon; P L Kaplan
Journal:  Cell       Date:  1987-04-10       Impact factor: 41.582

Review 3.  The molecular genetics of cancer.

Authors:  J M Bishop
Journal:  Science       Date:  1987-01-16       Impact factor: 47.728

4.  A noncatalytic domain conserved among cytoplasmic protein-tyrosine kinases modifies the kinase function and transforming activity of Fujinami sarcoma virus P130gag-fps.

Authors:  I Sadowski; J C Stone; T Pawson
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

5.  Myristic acid, a rare fatty acid, is the lipid attached to the transforming protein of Rous sarcoma virus and its cellular homolog.

Authors:  J E Buss; B M Sefton
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

6.  Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation.

Authors:  T E Kmiecik; D Shalloway
Journal:  Cell       Date:  1987-04-10       Impact factor: 41.582

7.  Tyrosine phosphorylation regulates the biochemical and biological properties of pp60c-src.

Authors:  H Piwnica-Worms; K B Saunders; T M Roberts; A E Smith; S H Cheng
Journal:  Cell       Date:  1987-04-10       Impact factor: 41.582

8.  Identification of an amino terminal domain required for the transforming activity of the Rous sarcoma virus src protein.

Authors:  V W Raymond; J T Parsons
Journal:  Virology       Date:  1987-10       Impact factor: 3.616

9.  Detection of phosphotyrosine-containing proteins in polyomavirus middle tumor antigen-transformed cells after treatment with a phosphotyrosine phosphatase inhibitor.

Authors:  W Yonemoto; A J Filson; A E Queral-Lustig; J Y Wang; J S Brugge
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

10.  Activation of the oncogenic potential of the avian cellular src protein by specific structural alteration of the carboxy terminus.

Authors:  A B Reynolds; J Vila; T J Lansing; W M Potts; M J Weber; J T Parsons
Journal:  EMBO J       Date:  1987-08       Impact factor: 11.598

View more
  56 in total

1.  Src homology region 2 domains direct protein-protein interactions in signal transduction.

Authors:  M F Moran; C A Koch; D Anderson; C Ellis; L England; G S Martin; T Pawson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

2.  Biological and biochemical activity of v-Crk chimeras containing the SH2/SH3 regions of phosphatidylinositol-specific phospholipase C-gamma and Src.

Authors:  M Matsuda; C T Reichman; H Hanafusa
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

3.  Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo.

Authors:  B J Mayer; P K Jackson; R A Van Etten; D Baltimore
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

4.  Multiple SH2-mediated interactions in v-src-transformed cells.

Authors:  C A Koch; M F Moran; D Anderson; X Q Liu; G Mbamalu; T Pawson
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

5.  Monoclonal antibodies to individual tyrosine-phosphorylated protein substrates of oncogene-encoded tyrosine kinases.

Authors:  S B Kanner; A B Reynolds; R R Vines; J T Parsons
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

6.  Glycoprotein tyrosine phosphorylation in Rous sarcoma virus-transformed chicken embryo fibroblasts.

Authors:  L M Kozma; A B Reynolds; M J Weber
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

7.  Individual Cas phosphorylation sites are dispensable for processive phosphorylation by Src and anchorage-independent cell growth.

Authors:  Parag Patwardhan; Yongquan Shen; Gary S Goldberg; W Todd Miller
Journal:  J Biol Chem       Date:  2006-05-17       Impact factor: 5.157

8.  Substrate recruitment to cyclin-dependent kinase 2 by a multipurpose docking site on cyclin A.

Authors:  B A Schulman; D L Lindstrom; E Harlow
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

9.  NSP-CAS Protein Complexes: Emerging Signaling Modules in Cancer.

Authors:  Yann Wallez; Peter D Mace; Elena B Pasquale; Stefan J Riedl
Journal:  Genes Cancer       Date:  2012-05

10.  SRC points the way to biomarkers and chemotherapeutic targets.

Authors:  Harini Krishnan; W Todd Miller; Gary S Goldberg
Journal:  Genes Cancer       Date:  2012-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.